• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA SRL INSPIRE 8F DUAL; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA SRL INSPIRE 8F DUAL; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 8F DUAL PH.I.S.I.O.
Device Problem Medical Gas Supply Problem (2985)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Livanova received a report that, an oxygenator replacement due to poor oxygenation.There is no report of any patient injury.
 
Manufacturer Narrative
Patient id, age, gender, weight and ethnicity: patient information were not provided.Involved oxygenator is unknown.The brand name was not communicated to livanova.This information will be provided in follow up report if available.Involved oxygenator is unknown.The catalogue number, lot number are unknown.Therefore, also expiry date and udi are unknown.This information will be provided in follow up report if available.Involved oxygenator is unknown.The catalogue number, lot number are unknown.Therefore, also manufacturing date is unknown.This information will be provided in follow up report if available.The incident occurred in (b)(6).The involved device has not yet been requested for return to sorin group (b)(4) for investigation.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
 
Manufacturer Narrative
Livanova has received a report about a poor oxygenation experienced by the customer while using a livanova inspire 8f during an emergency case; reportedly there was no impact to patients or users.Follow up with livanova representative was started and it was reported the following additional information: the poor oxygenation phenomenon was detected 2-3 minutes after the surgeon cross-clamped the aorta.The oxygenator replacement took 2 minutes and 20 seconds at blood temp of 33°c.The minimum value measured in arterial line was 47 mmhg and the associated hemoglobin oxygen saturation percentage was 80.9%.The act time measured when the gas exchange performance got worse was 502 seconds.The pump sheet of the case was analyzed and showed that fio2 was increased to 100% when low p02 values were measured in the arterial line, as recommended in the product ifu.Patient discharged in icu without any hemodynamic issue.After two days in sub-icu and after 8 days discharged at home.No information has been provided to livanova suggesting the medical team had investigated the low oxygenation phenomenon before changing the oxygenator out.Therefore, the phenomenon not being investigated, it is not possible to rule out that the poor oxygenation might have been related on how good the blood oxygenation in the patient was before the procedure has started.Since the low oxygenation was observed after 2-3 minutes after the aorta was cross-clamped, it is possible to determine that cardioplegia had not been administered yet to the patient and, therefore, the change took place in a lower critical step of the procedure.Despite requested, the oxygenator has not been received for investigation making it impossible to perform a physical investigation on the claimed device.A complaint database analysis was conducted and revealed that no further complaints have been filed for the mentioned lot on a total of 580 units manufactured.Based on the above and the investigation results of previous similar cases, it cannot be excluded that the most likely root cause of low oxygenation condition was a multifactorial issue, resulting from the interaction between clinical procedure, patient conditions and initial gas-blood settings.Indeed, with the evidence currently gathered, it cannot be concluded that the claimed phenomenon is fully attributable to an oxygenator deviation.No other specific action was currently deemed necessary, livanova will keep monitoring the market.
 
Event Description
See intial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRE 8F DUAL
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
SORIN GROUP ITALIA SRL
strada statale 12 nord, 86
mirandola
Manufacturer (Section G)
SORIN GROUP ITALIA SRL
strada statale 12 nord, 86
mirandola 41037
IT   41037
Manufacturer Contact
enrico greco
14401 w 65th way
arvada, CO 80004
MDR Report Key13258091
MDR Text Key286731166
Report Number9680841-2022-00003
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier08033178112420
UDI-Public(01)08033178112420(17)240927(10)2109290056(11)210929(240)050720
Combination Product (y/n)N
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8F DUAL PH.I.S.I.O.
Device Catalogue Number050720
Device Lot Number2109290056
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received07/26/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-